中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
Chinese Journal of Immunology
2015年
10期
1385-1388
,共4页
饶和平%方美新%王炜%卢伟力%姚水洪%叶剑华
饒和平%方美新%王煒%盧偉力%姚水洪%葉劍華
요화평%방미신%왕위%로위력%요수홍%협검화
儿童艾滋病%HBV/HCV%HAART%肝损伤%病毒载量
兒童艾滋病%HBV/HCV%HAART%肝損傷%病毒載量
인동애자병%HBV/HCV%HAART%간손상%병독재량
Pediatric AIDS patients%HBV/HCV%HAART%Liver injury%HIV viral load
目的:观察艾滋病合并HBV/HCV感染患儿HAART治疗后肝功能、病毒载量、CD4+T细胞变化特点,探讨艾滋病患儿合并HBV/HCV感染对HAART效果的影响。方法:单纯HIV感染95例( A组), HIV合并HBV感染9例( B组), HIV合并HCV感染23例( C组)。患儿均接受HAART治疗2年左右,检测治疗前后三组肝功能、病毒载量、CD4+T细胞,并进行比较。结果:HAART治疗后2级(100<ALT≤200μ/L且TBIL≤51.25μmol/L)以上肝毒性肝损伤26例(20.5%),三组比较有统计学差异(χ2=37.94,P<0.01),合并HCV感染组明显高于单纯感染组(χ2=12.60,P<0.01)。治疗后三组在ALT有统计学差异(P<0.05),且C组在ALT与TBIL二项明显高于A组(t值分别为10.53与1.37,P<0.05)。 HAART治疗后各组CD4+T细胞明显升高(P<0.01),病毒载量(HIV-RNA)明显减低(P<0.01),治疗后三组间CD4+T细胞及病毒载量比较无统计学意义( P>0.05)。结论:HIV合并HBV/HCV感染可增加肝毒性肝损伤,但对HAART治疗效果的影响有限。
目的:觀察艾滋病閤併HBV/HCV感染患兒HAART治療後肝功能、病毒載量、CD4+T細胞變化特點,探討艾滋病患兒閤併HBV/HCV感染對HAART效果的影響。方法:單純HIV感染95例( A組), HIV閤併HBV感染9例( B組), HIV閤併HCV感染23例( C組)。患兒均接受HAART治療2年左右,檢測治療前後三組肝功能、病毒載量、CD4+T細胞,併進行比較。結果:HAART治療後2級(100<ALT≤200μ/L且TBIL≤51.25μmol/L)以上肝毒性肝損傷26例(20.5%),三組比較有統計學差異(χ2=37.94,P<0.01),閤併HCV感染組明顯高于單純感染組(χ2=12.60,P<0.01)。治療後三組在ALT有統計學差異(P<0.05),且C組在ALT與TBIL二項明顯高于A組(t值分彆為10.53與1.37,P<0.05)。 HAART治療後各組CD4+T細胞明顯升高(P<0.01),病毒載量(HIV-RNA)明顯減低(P<0.01),治療後三組間CD4+T細胞及病毒載量比較無統計學意義( P>0.05)。結論:HIV閤併HBV/HCV感染可增加肝毒性肝損傷,但對HAART治療效果的影響有限。
목적:관찰애자병합병HBV/HCV감염환인HAART치료후간공능、병독재량、CD4+T세포변화특점,탐토애자병환인합병HBV/HCV감염대HAART효과적영향。방법:단순HIV감염95례( A조), HIV합병HBV감염9례( B조), HIV합병HCV감염23례( C조)。환인균접수HAART치료2년좌우,검측치료전후삼조간공능、병독재량、CD4+T세포,병진행비교。결과:HAART치료후2급(100<ALT≤200μ/L차TBIL≤51.25μmol/L)이상간독성간손상26례(20.5%),삼조비교유통계학차이(χ2=37.94,P<0.01),합병HCV감염조명현고우단순감염조(χ2=12.60,P<0.01)。치료후삼조재ALT유통계학차이(P<0.05),차C조재ALT여TBIL이항명현고우A조(t치분별위10.53여1.37,P<0.05)。 HAART치료후각조CD4+T세포명현승고(P<0.01),병독재량(HIV-RNA)명현감저(P<0.01),치료후삼조간CD4+T세포급병독재량비교무통계학의의( P>0.05)。결론:HIV합병HBV/HCV감염가증가간독성간손상,단대HAART치료효과적영향유한。
Objective:To investigate the change of liver function,viral load and CD4+T count in pediatric AIDS patients with HBV/HCV co-infection after HARRT therapy,and explore the effect of HBV/HCV co-infection on HAART.Methods:95 pediatric AIDS patients without HBV/HCV co-infection ( group A) ,9 pediatric AIDS patients with HBV co-infection ( group B) and 23 pediatric AIDS patients with HCV co-infection ( group C) who received HAART for 2 year were enrolled.Liver function,viral load and CD4+T count were detected before and after HAART.Results:After HAART for 2 years,26 patients (20.5%) were found with liver injury of grade 2 (100<ALT≤200 U/L and TBIL≤51.25μmol/L) (χ2=37.94,P<0.01) ,more patients with liver injury of grade 2 in group C than in group A (χ2=12.60,P<0.01).ALT and TBIL of patients in group C was much higher than that in group A (t value was 10.53 and 1.37,P<0.05).CD4+T cell counts were increased (P<0.01) and viral load (HIV-RNA) was decreased (P<0.01) after two years of HAART, no difference was found among three groups of patients ( P>0.05 ) .Conclusion: Co-infection of HBV/HCV can aggravate the liver damage of HIV-1 infected children,but has no significant effect on HAART.